Please assess the completion status of the following clinical trial:

Trial Title: Recovery of Hibernating Myocardium in End Stage Heart Failure

Study Design Characteristics:
- Allocation: None
- Intervention Model: None
- Observational Model: COHORT
- Primary Purpose: None
- Time Perspective: PROSPECTIVE
- Masking: None
- Phase: None
- Number of Arms: None

Eligibility Criteria:
Inclusion Criteria:~1. Male or non-pregnant female \>= 18 years of age.~2. End stage chronic and dilated ischemic cardiomyopathy requiring LVAD support.~3. Ability to understand and sign a written informed consent form, which must be obtained prior to initiation of any study procedures.~Ischemic cardiomyopathy is defined by a LVEF \< 40% and any of the following:~* History of myocardial infarction or revascularization.~* History of angina or chest pain and evidence of scarring in non-invasive imaging studies corresponding to previous myocardial infarction.~* Presence of ≥ 75% stenosis of the left main or proximal left anterior descending artery, or ≥ 75% stenosis of 2 or more epicardial vessels in a patient with unexplained cardiomyopathy.~Exclusion Criteria:~* Pregnant and/or lactating women and women of child bearing potential who are not using acceptable means of contraception. Women of childbearing potential must be using adequate measures of contraception (as determined by the Investigator) to avoid pregnancy and should be highly unlikely to conceive during the study period. Women of childbearing potential must have a negative pregnancy test at screen.~* Patients with acute forms of HF: acute onset of symptoms \< 3 months, no left and right ventricular dilation.~* Other conditions that in the opinion of the Principal Investigator may increase risk to the subject and/or compromise the quality of the clinical trial.

- Gender: ALL
- Minimum Age: 18 Years
- Maximum Age: None
- Healthy Volunteers: f

Based on this trial design, predict the completion outcome and termination type (if applicable).